Market Overview
Electroporation is a microbiology method that employs an electrical pulse to produce temporary gaps in cell membranes that allow things like nucleic acids to enter cells. Electroporation can be used for all cell types, including mammalian bacteria, algae, plants, and yeast. It employs an electrical current that is precisely pulsed to produce temporary gaps in the cell membrane through which molecules may subsequently flow. Some applications of electroporation are deoxyribonucleic acid transfection or transformation, direct transfer of plasmids across cells, induced cell fusion, trans-dermal medication administration, and malignant tumour electro-chemotherapy and gene therapy.
Download Free PDF Sample: Click Here
Market Growth Analysis
As per DataM Intelligence’s latest report, the “Global Electroporation Instruments Market” is estimated to grow at a CAGR of 6.9% during the forecast period 2023 – 2030.
Electroporation Instruments Market: Drivers
The development of vaccine delivery systems employing electroporation technology is likely to fuel growth during the projection period
The electroporation technique is widely preferred to enhance nucleic acid uptake with the DNA to generate an immune response against an antigen when the vaccine is given via the skin. The increased frequency of viral diseases and other skin ailments is expected to stimulate demand for electroporation tools. The ability of electrophoresis to locate local antigen expression in the epidermis provides a considerable benefit to patients. Because the electroporation approach produces an inflammatory milieu, its combination with DNA vaccination would result in high antigen expression, propelling the global electroporation instruments market.
Increasing product approvals and launches are anticipated to drive the global electroporation instruments market forward throughout the forecast period.
Product approvals and launches are projected to boost the global electroporation instruments market during the forecast period.
For example, Thermo Fisher Scientific Inc., an American provider of scientific apparatus, reagents, consumables, and software services, announced the release of the Gibco CTS Xenon Electroporation System on April 2, 2022. The product is meant to facilitate the development of cell treatments.
In addition, MaxCyte, a worldwide clinical-stage cell-based therapeutics and life sciences firm, announced the introduction of the first product in its revamped and enlarged ExPERT disposables line on June 25, 2020. The R-1000 cuvette can handle up to one mL, or 200 million cells, and provides increased adaptability for firms researching cell therapy medications as well as those conducting early drug development. These new cuvette designs are compatible with the whole MaxCyte electroporation equipment line.
Market Growth Opportunities
Increasing R&D Activities Provide Lucrative Opportunities
Researchers are increasingly using numerous technologically enhanced gene editing strategies for curating targeted sequence-specific alternations throughout the DNA. A few sophisticated gene editing methods include clustered, regularly interspaced short palindromic repeats (CRISPR), CRISPR-associated (Cas) proteins, and transcription activator-like effector nucleases (TALENs). A growth in similar R&D efforts is expected to give more opportunities to utilize electroporation instruments during the forecasted years.
Raising Strategic Collaborations or Acquisitions
Market players are implementing initiatives such as collaborations, partnerships, and acquisitions, which are projected to contribute to the global electroporation instruments market’s growth throughout the forecast period. This would create favourable opportunities for the growth of the electroporation instruments market.
Furthermore, increased investment in advanced technology research and a rise in the number of new markets will create further prospects for the expansion of electroporation instruments throughout the projection period.
Electroporation Instruments Market: Segmentation Analysis
The Global Electroporation Instruments Market is segmented by product into total electroporation systems, eukaryotic electroporation system, and microbial electroporation system; and by application into protein production, bio-medical research, and therapeutic delivery.
Based on the Product, the Total Electroporation System Segment is Expected to Hold Largest Share
The growing global disease load has encouraged numerous healthcare institutions to concentrate on medication research and development. These investigations need the use of experimental medications on human and other eukaryotic cells in order to investigate their mechanism of action and safety profile. The complete electroporation system is expected to be driven by an increase in demand for diverse devices that can be utilized for various sorts of cell investigations, resulting in overall cost-effectiveness during the projection period.
For more detailed information: Click Here
Industry Developments
- In April 2022, Thermo Fisher Scientific Inc., an American manufacturer of scientific instruments, reagents, consumables, and software services, launched its Gibco CTS Xenon Electroporation System.
- MaxCyte, a global company involved in clinical-stage cell-based medicines and life sciences, introduced the R-1000 cuvette in June 2020, which can process up to one mL or 200 million cells and provides greater versatility for companies developing cell therapy drugs as well as those advancing early drug discovery. These new cuvette designs are compatible with the whole MaxCyte electroporation equipment line.
Regional Insights
By region, the global electroporation instruments market is segmented into North America, Europe, South America, Asia Pacific, and Middle East and Africa.
North America led the global market for electroporation instruments, followed by Europe. The increased prevalence of cancer and autoimmune illnesses in North America fueled the demand for transfection technology. Furthermore, biotherapeutic medications are largely chosen for the treatment of cancer and autoimmune illnesses, and growth in their use is expected to drive demand for transfection since transfection is widely used in the production of biotherapeutic pharmaceuticals.
Competitive Landscape
Some of the key players contributing to the global electroporation instruments market growth include BEX Co. Ltd., Celetrix LLC, Merck KGaA, Eppendorf AG, Harvard Bioscience Inc. (BTX), Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, MaxCyte Inc., Lonza Group, and Mirus Bio LLC, Guangzhou Tingmay Beauty Equipment Co., Ltd, ALLFOND INDUSTRIAL LIMITED, Shanghai Apolo Medical Technology Co., Ltd.
Bio-Rad Laboratories Overview
Bio-Rad, founded in 1952, is a global leader in developing, manufacturing and marketing a broad range of innovative products for the life science research and clinical diagnostic markets, with employees of more than 7,800 headquarters in Hercules, California, USA.
Bio-Rad is among the top five life science companies globally, providing instruments, software, consumables, reagents, and content for cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. It is the world leader in clinical quality control products, services, and information systems, ensuring the accuracy and validity of clinical test results.
About DataM Intelligence
DataM Intelligence 4Market Research is a Market Research firm that provides end-to-end business solutions to organizations from Research to Consulting. We at DataM Intelligence leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of Syndicate Reports & and; Customized Reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.
Trending Topics
Transcatheter Mitral Valve Repair Devices Market
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Send Email
Phone: 08774414866
Address:DATAM INTELLIGENCE 4MARKET RESEARCH LLP Ground floor, DSL Abacus IT Park, Industrial Development Area, Uppal, Hyderabad, Telangana 500039
City: HYDERABAD
State: Telangana
Country: India
Website: https://www.datamintelligence.com/research-report/electroporation-instruments-market